Assessed contributions
Assessed contributions (AC) are the amounts each of the 196 Members and Associate Members must pay to WHO on an annual basis. The assessment scale is calculated by the United Nations based mainly on the country’s GDP and is adjusted for WHO’s membership. It is approved every two years by the World Health Assembly (refer to the latest approved assessment scale resolution attached here).
Assessed contributions are a key source of financing for the Organization, providing predictable financing, helping to minimize the dependence on a narrow donor base, and allowing resources to be aligned to the Programme Budget. Assessed contributions have declined as an overall percentage of the Programme Budget and have, for several years, accounted for less than 20% of the Organization’s financing. The balance is mobilized through voluntary contributions.
Other documents
All →Assessed contributions payable summary 2026-2027 Assessed contributions payable summary 2026-2027
Scale of assessments for 2026/2027 Scale of assessments for 2026/2027
Assessed contributions overview for all Member States as at 31 December 2024 Assessed contributions overview for all Member States as at 31 December 2024
Scale of assessments for 2024/2025 (EB152.R3) Scale of assessments for 2024/2025 (EB152.R3)
Assessed contributions payable summary 2024-2025 Assessed contributions payable summary 2024-2025
Notice of Assessments and Statements of Account
All →Click the All button to search for the latest Notice of Assessment and Individual Statements of Account by Member State and by year. Notice of assessments are available for each biennium, please select 2020 as dropdown filter.
Meningitis Weekly Bulletin Weeks 32-35, 2026
Meningitis Weekly Bulletin Weeks 32-35, 2026 3 to 30 August 2026
Recommended composition of influenza virus vaccines for use in the 2027 southern hemisphere influenza...
For vaccines for use in the 2027 southern hemisphere influenza season, WHO recommends the following: Egg-based vaccines • an A/Missouri/11/2025 (H1N1)pdm09-like...
Zoonotic candidate vaccine viruses and potency testing reagents for development and production of vaccines
The candidate vaccine viruses listed below, and associated information, are available for the development and production of vaccines against zoonotic influenza...
Seasonal candidate vaccine viruses and potency testing reagents for development and production of vaccines
The candidate vaccine viruses listed below, and associated information, are available for the development and production of influenza vaccines for use...
WHO and HRP programme at SVRI
This document provides a curated list of events hosted by WHO and HRP at SVRI.
Global Respiratory Virus Activity: Weekly Update N° 596
In week 37 2026, globally, influenza positivity was at 10% and SARS-CoV-2 positivity remained stable and low. Influenza positivity was under 10% in the...
Middle East Escalation of Conflict, Global external situation report #11 - 15 September 2026
This is the 11th global public WHO situation report on the conflict in the Middle East. It covers the health situation and WHO operational updates from...